Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette disorder

Identifieur interne : 000323 ( Pmc/Curation ); précédent : 000322; suivant : 000324

Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette disorder

Auteurs : Pablo R. Moya [États-Unis] ; Jens R. Wendland [États-Unis] ; Liza M. Rubenstein [États-Unis] ; Kiara R. Timpano [États-Unis] ; Gary A. Heiman [États-Unis] ; Jay A. Tischfield [États-Unis] ; Robert A. King [États-Unis] ; Anne M. Andrews [États-Unis] ; Samanda Ramamoorthy [États-Unis] ; Francis J. Mcmahon [États-Unis] ; Dennis L. Murphy [États-Unis]

Source :

RBID : PMC:3766488

Abstract

BACKGROUND

To evaluate the hypothesis that functionally over-expressing alleles of the serotonin transporter gene SLC6A4 are present in Tourette disorder (TD), just as we have found in obsessive compulsive disorder (OCD), we evaluated TD probands (N=151) and controls (N=858).

METHODS

We genotyped the refined 5-HTTLPR/rs25531 locus and the associated rs25532 variant in the SLC6A4 promoter plus the rare coding variant SERT I425V.

RESULTS

The higher-expressing 5-HTTLPR/rs25531 LA allele was more prevalent in TD probands than controls (χ2=5.75, p=0.017, OR=1.35), and in a secondary analysis, surprisingly found to be significantly more frequent in probands with TD alone than in those with TD plus OCD (Fisher's exact test, p=0.0006, OR=2.29). Likewise, the higher-expressing LAC haplotype (5-HTTLPR/rs25531/rs25532) was more frequent in TD probands than controls (p=0.024, OR=1.33) and likewise in the TD alone versus TD plus OCD group (p=0.0013, OR=2.14). Further, the rare gain-of-function SERT I425V variant was found in three male siblings with TD and/or OCD and in their father. The cumulative count of SERT I425V thus becomes 1.57% in OCD/TD spectrum conditions vs. 0.15% in controls, with a recalculated, family-adjusted significance of χ2=15.03, p < 0.0001, OR=9.0 (total worldwide genotyped=2914).

CONCLUSIONS

This report provides a unique combination of common and rare variants in one gene in TD, all found to be associated with SLC6A4 gain of function. Thus, altered SERT activity represents a potential contributor to serotonergic abnormalities in TD. Present results call for replication in a similarly intensively evaluated sample.


Url:
DOI: 10.1002/mds.25460
PubMed: 23630162
PubMed Central: 3766488

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:3766488

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Common and rare alleles of the serotonin transporter gene,
<italic>SLC6A4</italic>
, associated with Tourette disorder</title>
<author>
<name sortKey="Moya, Pablo R" sort="Moya, Pablo R" uniqKey="Moya P" first="Pablo R" last="Moya">Pablo R. Moya</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wendland, Jens R" sort="Wendland, Jens R" uniqKey="Wendland J" first="Jens R" last="Wendland">Jens R. Wendland</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rubenstein, Liza M" sort="Rubenstein, Liza M" uniqKey="Rubenstein L" first="Liza M" last="Rubenstein">Liza M. Rubenstein</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Timpano, Kiara R" sort="Timpano, Kiara R" uniqKey="Timpano K" first="Kiara R" last="Timpano">Kiara R. Timpano</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Psychology, University of Miami, Coral Gables, FL</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Psychology, University of Miami, Coral Gables</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Heiman, Gary A" sort="Heiman, Gary A" uniqKey="Heiman G" first="Gary A" last="Heiman">Gary A. Heiman</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Tischfield, Jay A" sort="Tischfield, Jay A" uniqKey="Tischfield J" first="Jay A" last="Tischfield">Jay A. Tischfield</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="King, Robert A" sort="King, Robert A" uniqKey="King R" first="Robert A" last="King">Robert A. King</name>
<affiliation wicri:level="2">
<nlm:aff id="A4">Child Study Center of Yale University, New Haven, CT</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Child Study Center of Yale University, New Haven</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Andrews, Anne M" sort="Andrews, Anne M" uniqKey="Andrews A" first="Anne M" last="Andrews">Anne M. Andrews</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Semel Institute for Neuroscience and Human Behavior and California Nano Systems Institute, University of California, Los Angeles, CA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Semel Institute for Neuroscience and Human Behavior and California Nano Systems Institute, University of California, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ramamoorthy, Samanda" sort="Ramamoorthy, Samanda" uniqKey="Ramamoorthy S" first="Samanda" last="Ramamoorthy">Samanda Ramamoorthy</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Francis J" sort="Mcmahon, Francis J" uniqKey="Mcmahon F" first="Francis J" last="Mcmahon">Francis J. Mcmahon</name>
<affiliation wicri:level="2">
<nlm:aff id="A7">Human Genetics Branch, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Human Genetics Branch, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Murphy, Dennis L" sort="Murphy, Dennis L" uniqKey="Murphy D" first="Dennis L" last="Murphy">Dennis L. Murphy</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23630162</idno>
<idno type="pmc">3766488</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766488</idno>
<idno type="RBID">PMC:3766488</idno>
<idno type="doi">10.1002/mds.25460</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000323</idno>
<idno type="wicri:Area/Pmc/Curation">000323</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Common and rare alleles of the serotonin transporter gene,
<italic>SLC6A4</italic>
, associated with Tourette disorder</title>
<author>
<name sortKey="Moya, Pablo R" sort="Moya, Pablo R" uniqKey="Moya P" first="Pablo R" last="Moya">Pablo R. Moya</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wendland, Jens R" sort="Wendland, Jens R" uniqKey="Wendland J" first="Jens R" last="Wendland">Jens R. Wendland</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rubenstein, Liza M" sort="Rubenstein, Liza M" uniqKey="Rubenstein L" first="Liza M" last="Rubenstein">Liza M. Rubenstein</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Timpano, Kiara R" sort="Timpano, Kiara R" uniqKey="Timpano K" first="Kiara R" last="Timpano">Kiara R. Timpano</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Psychology, University of Miami, Coral Gables, FL</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Psychology, University of Miami, Coral Gables</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Heiman, Gary A" sort="Heiman, Gary A" uniqKey="Heiman G" first="Gary A" last="Heiman">Gary A. Heiman</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Tischfield, Jay A" sort="Tischfield, Jay A" uniqKey="Tischfield J" first="Jay A" last="Tischfield">Jay A. Tischfield</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="King, Robert A" sort="King, Robert A" uniqKey="King R" first="Robert A" last="King">Robert A. King</name>
<affiliation wicri:level="2">
<nlm:aff id="A4">Child Study Center of Yale University, New Haven, CT</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Child Study Center of Yale University, New Haven</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Andrews, Anne M" sort="Andrews, Anne M" uniqKey="Andrews A" first="Anne M" last="Andrews">Anne M. Andrews</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Semel Institute for Neuroscience and Human Behavior and California Nano Systems Institute, University of California, Los Angeles, CA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Semel Institute for Neuroscience and Human Behavior and California Nano Systems Institute, University of California, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ramamoorthy, Samanda" sort="Ramamoorthy, Samanda" uniqKey="Ramamoorthy S" first="Samanda" last="Ramamoorthy">Samanda Ramamoorthy</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Francis J" sort="Mcmahon, Francis J" uniqKey="Mcmahon F" first="Francis J" last="Mcmahon">Francis J. Mcmahon</name>
<affiliation wicri:level="2">
<nlm:aff id="A7">Human Genetics Branch, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Human Genetics Branch, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Murphy, Dennis L" sort="Murphy, Dennis L" uniqKey="Murphy D" first="Dennis L" last="Murphy">Dennis L. Murphy</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>BACKGROUND</title>
<p id="P9">To evaluate the hypothesis that functionally over-expressing alleles of the serotonin transporter gene
<italic>SLC6A4</italic>
are present in Tourette disorder (TD), just as we have found in obsessive compulsive disorder (OCD), we evaluated TD probands (N=151) and controls (N=858).</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P10">We genotyped the refined 5-HTTLPR/rs25531 locus and the associated rs25532 variant in the
<italic>SLC6A4</italic>
promoter plus the rare coding variant SERT I425V.</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P11">The higher-expressing 5-HTTLPR/rs25531 L
<sub>A</sub>
allele was more prevalent in TD probands than controls (χ
<sup>2</sup>
=5.75, p=0.017, OR=1.35), and in a secondary analysis, surprisingly found to be significantly more frequent in probands with TD alone than in those with TD plus OCD (Fisher's exact test, p=0.0006, OR=2.29). Likewise, the higher-expressing L
<sub>AC</sub>
haplotype (5-HTTLPR/rs25531/rs25532) was more frequent in TD probands than controls (p=0.024, OR=1.33) and likewise in the TD alone versus TD plus OCD group (p=0.0013, OR=2.14). Further, the rare gain-of-function SERT I425V variant was found in three male siblings with TD and/or OCD and in their father. The cumulative count of SERT I425V thus becomes 1.57% in OCD/TD spectrum conditions vs. 0.15% in controls, with a recalculated, family-adjusted significance of χ
<sup>2</sup>
=15.03, p < 0.0001, OR=9.0 (total worldwide genotyped=2914).</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P12">This report provides a unique combination of common and rare variants in one gene in TD, all found to be associated with
<italic>SLC6A4</italic>
gain of function. Thus, altered SERT activity represents a potential contributor to serotonergic abnormalities in TD. Present results call for replication in a similarly intensively evaluated sample.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Mov. Disord.</journal-id>
<journal-title-group>
<journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">23630162</article-id>
<article-id pub-id-type="pmc">3766488</article-id>
<article-id pub-id-type="doi">10.1002/mds.25460</article-id>
<article-id pub-id-type="manuscript">NIHMS461150</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Common and rare alleles of the serotonin transporter gene,
<italic>SLC6A4</italic>
, associated with Tourette disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moya</surname>
<given-names>Pablo R</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wendland</surname>
<given-names>Jens R</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>Liza M</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Timpano</surname>
<given-names>Kiara R</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heiman</surname>
<given-names>Gary A</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tischfield</surname>
<given-names>Jay A</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>King</surname>
<given-names>Robert A</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrews</surname>
<given-names>Anne M</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramamoorthy</surname>
<given-names>Samanda</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McMahon</surname>
<given-names>Francis J</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Murphy</surname>
<given-names>Dennis L</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>
Laboratory of Clinical Science, NIMH-Intramural Research Program, Bethesda, MD</aff>
<aff id="A2">
<label>2</label>
Department of Psychology, University of Miami, Coral Gables, FL</aff>
<aff id="A3">
<label>3</label>
Human Genetics Institute of New Jersey and Department of Genetics, Rutgers University, Piscataway, NJ</aff>
<aff id="A4">
<label>4</label>
Child Study Center of Yale University, New Haven, CT</aff>
<aff id="A5">
<label>5</label>
Semel Institute for Neuroscience and Human Behavior and California Nano Systems Institute, University of California, Los Angeles, CA</aff>
<aff id="A6">
<label>6</label>
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA</aff>
<aff id="A7">
<label>7</label>
Human Genetics Branch, NIMH-Intramural Research Program, Bethesda, MD</aff>
<author-notes>
<fn id="FN1" fn-type="present-address">
<label>#</label>
<p id="P1">Present address: Worldwide R&D, Pfizer Inc, Cambridge, MA, USA</p>
</fn>
<fn id="FN2">
<p id="P2">P.R. Moya: Conceived, organized and executed the research project; executed statistical analysis; wrote first manuscript draft.</p>
<p id="P3">D.L. Murphy: Conceived research project; executed and reviewed statistical analysis; reviewed and critiqued manuscript.</p>
<p id="P4">J.R. Wendland: Conceived research project; designed, executed and reviewed statistical analysis; reviewed and critiqued manuscript.</p>
<p id="P5">L.M. Rubenstein: Performed experimental work and statistical analysis; reviewed and critiqued manuscript.</p>
<p id="P6">K.C. Timpano: Conceived research project; recruited FL healthy volunteers Reviewed and critiqued statistical analysis; reviewed and critiqued manuscript.</p>
<p id="P7">G.A. Heiman, J.A. Tischfield and R.A. King: Recruited and clinically characterized Tourette probands; reviewed statistical analysis; reviewed and critiqued manuscript.</p>
<p id="P8">S. Ramamoorthy, A.M. Andrews and F.J. McMahon: Reviewed and critiqued statistical analysis; reviewed and critiqued manuscript.</p>
</fn>
<corresp id="CR1">
<underline>Corresponding author</underline>
Pablo R. Moya, PhD Laboratory of Clinical Science, NIMH-IRP 10/3D41 10 Center Dr Bethesda, MD 20892 Phone 301-5940126; Fax 301-4020188
<email>moyap@mail.nih.gov</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>4</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>4</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2014</year>
</pub-date>
<volume>28</volume>
<issue>9</issue>
<fpage>1263</fpage>
<lpage>1270</lpage>
<abstract>
<sec id="S1">
<title>BACKGROUND</title>
<p id="P9">To evaluate the hypothesis that functionally over-expressing alleles of the serotonin transporter gene
<italic>SLC6A4</italic>
are present in Tourette disorder (TD), just as we have found in obsessive compulsive disorder (OCD), we evaluated TD probands (N=151) and controls (N=858).</p>
</sec>
<sec id="S2">
<title>METHODS</title>
<p id="P10">We genotyped the refined 5-HTTLPR/rs25531 locus and the associated rs25532 variant in the
<italic>SLC6A4</italic>
promoter plus the rare coding variant SERT I425V.</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P11">The higher-expressing 5-HTTLPR/rs25531 L
<sub>A</sub>
allele was more prevalent in TD probands than controls (χ
<sup>2</sup>
=5.75, p=0.017, OR=1.35), and in a secondary analysis, surprisingly found to be significantly more frequent in probands with TD alone than in those with TD plus OCD (Fisher's exact test, p=0.0006, OR=2.29). Likewise, the higher-expressing L
<sub>AC</sub>
haplotype (5-HTTLPR/rs25531/rs25532) was more frequent in TD probands than controls (p=0.024, OR=1.33) and likewise in the TD alone versus TD plus OCD group (p=0.0013, OR=2.14). Further, the rare gain-of-function SERT I425V variant was found in three male siblings with TD and/or OCD and in their father. The cumulative count of SERT I425V thus becomes 1.57% in OCD/TD spectrum conditions vs. 0.15% in controls, with a recalculated, family-adjusted significance of χ
<sup>2</sup>
=15.03, p < 0.0001, OR=9.0 (total worldwide genotyped=2914).</p>
</sec>
<sec id="S4">
<title>CONCLUSIONS</title>
<p id="P12">This report provides a unique combination of common and rare variants in one gene in TD, all found to be associated with
<italic>SLC6A4</italic>
gain of function. Thus, altered SERT activity represents a potential contributor to serotonergic abnormalities in TD. Present results call for replication in a similarly intensively evaluated sample.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>SLC6A4</italic>
</kwd>
<kwd>SERT</kwd>
<kwd>Tourette</kwd>
<kwd>serotonin</kwd>
<kwd>5-HTTLPR</kwd>
<kwd>SERT I425V</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>R01 MH092293 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>R01 MH064756 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>ZIA MH000336-30 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>Z99 MH999999 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>Z99 MH999999 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>Z99 MH999999 || MH</award-id>
</award-group>
<award-group>
<funding-source country="United States">National Institute of Mental Health : NIMH</funding-source>
<award-id>Z01 MH000336-28 || MH</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000323 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000323 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:3766488
   |texte=   Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette disorder
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:23630162" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024